Immunotherapy-based adjuvant treatment after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma according to pathological response

BackgroundNeoadjuvant immunochemotherapy (NICT) is increasingly used in patients with locally advanced resectable esophageal squamous cell carcinoma (ESCC). However, optimal postoperative adjuvant treatment strategies remain unclear. This study aimed to evaluate the efficacy of immunotherapy-based a...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Chenyu Wang, Xiaoran Geng, Xinyu Cheng, Runchuan Ren, Linzhi Jin, Zhaojie Sheng, Shenglei Li, Meiling Zang, Yaowen Zhang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Frontiers Media S.A. 2026-06-01
Rangatū:	Frontiers in Immunology
Ngā marau:	esophageal squamous cell carcinoma immunotherapy-based adjuvant treatment neoadjuvant immunochemotherapy pathological complete response pathological downstaging
Urunga tuihono:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1802037/full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!